Variation in the Commissioning of Semaglutide for the Treatment of Obesity and Overweight Across England: Results of Three Freedom of Information‐Based Mapping Exercises Across the 42 Integrated Care Boards of England.

Saved in:
Bibliographic Details
Title: Variation in the Commissioning of Semaglutide for the Treatment of Obesity and Overweight Across England: Results of Three Freedom of Information‐Based Mapping Exercises Across the 42 Integrated Care Boards of England.
Authors: de Bray, Anne1,2 (AUTHOR), Schnitzer, Hanna3 (AUTHOR), Mahase, Elisabeth4 (AUTHOR), Singh, Puspha5,6,7 (AUTHOR), Andrews, Rob8 (AUTHOR), McGowan, Barbara M.9 (AUTHOR), Le Brocq, Sarah10 (AUTHOR), Wilding, John P. H.11 (AUTHOR), Flint, Stuart W.12,13 (AUTHOR), Hazlehurst, Jonathan M.5,6,7 (AUTHOR) j.m.hazlehurst@bham.ac.uk
Source: Clinical Obesity. Feb2026, Vol. 16 Issue 1, p1-8. 8p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17588103
DOI:10.1111/cob.70044